“NMR Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells”, Radiol Oncol, vol. 52, no. 4, Dec. 2018, Accessed: Sep. 24, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/2963